![]() Financial Daily from THE HINDU group of publications Thursday, September 11, 2003 |
|
||||||||||||
|
|
|||||||||||||
|
VARIETY HEALTH Cadila Pharma launches new cardiovascular drug THE Cadila Pharmaceuticals Ltd (CPL) has fortified its cardiovascular basket of products with the nitric oxide donating beta-1 blocker, nebivilol, under the brand name, Nodon. With this product launch, CPL has become the first indigenous bulk ... More ENTERTAINMENT & LEISURE 2 weeks time given to file reply to SitiCable's plea ZEE'S ambitious plans of getting signals of popular channels such as Star, Sony and ESPN on its head-end in the sky (HITS) platform will have to wait. The Monopolies and Restrictive Trade Practices Commission (MRTPC) on Wednesday gave the ... More
SAB TV on DTH platform in UK SPORTS Maharashtra mulls Formula One circuit Recently, political leader, Mr Sharad Pawar, held a meeting with Mr Nazir Hoosein, President of Motorsports Association of India (MAI), to outline plans for a proposed Formula One racing circuit. ``With the expressway already in place between ... More PEOPLE Doctor does 25,000 heart surgeries Chennai: Dr M.R. Girinath, Chief Cardiovascular Surgeon, Apollo Hospitals, was felicitated by the hospital management on Tuesday on performing 25,000 heart surgeries there. An Apollo press release said of the 25,000 surgeries performed ... More Comments & Letters to the Editor to: bleditor@thehindu.co.in Subscribe to: Business Line |
![]() Pick a Winner Stock Market Contest
Top Stories In Focus Cola Controversy The Cable tangle Indo-China Relations Telecom Competition Oil PSUs: Disinvestment dilemma In Depth In Kashmir Simple Economics Slowburn Tax Talk NRIs & Investment Avenues Corporate Governance Looking back Aug. 31-Sep. 6 A safe spend to save cash Naidu's Formula One dreams for Andhra |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home | Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line |